Sign in
4

Changes in Ownership

MAIA Biotechnology, Inc. Filed Acc 0001127602-23-000649

Options or other derivatives

  • Director acquired 3,807 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Smith Stan · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-12-30 Grant or award : show line 1 in the form Stock Options +3,807 $3.51 2032-12-30 3,807 3,807 I
Loading xslF345X03/form4.xml…